(Q38185026)

30 August 2017

1 reference

title

Arabinosyl-5-azacytosine: a novel nucleoside entering clinical trials (English)

1 reference

30 August 2017

J L Grem

1

1 reference

30 August 2017

D D Shoemaker

2

1 reference

30 August 2017

D F Hoth

3

1 reference

30 August 2017

S A King

4

1 reference

30 August 2017

J Plowman

5

1 reference

30 August 2017

D Zaharko

6

1 reference

30 August 2017

C K Grieshaber

7

1 reference

30 August 2017

S D Harrison

8

1 reference

30 August 2017

J C Cradock

9

1 reference

30 August 2017

B Leyland-Jones

10

1 reference

30 August 2017

publication date

1 December 1987

1 reference

Investigational New Drugs

30 August 2017

published in

1 reference

30 August 2017

volume

5

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

315-328

1 reference

DNA Methylation and Gene Function

30 August 2017

cites work

1 reference

12 December 2020

Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells

1 reference

12 December 2020

Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes

1 reference

12 December 2020

Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5-azacytosine arabinoside (NSC 281272) and 5-azacytidine (NSC 102816)

1 reference

12 December 2020

Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells

1 reference

12 December 2020

Kinetics and Mechanisms of Degradation of the Antileukemic Agent 5‐Azacytidine in Aqueous Solutions

1 reference

12 December 2020

Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.

1 reference

12 December 2020

Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.

1 reference

12 December 2020

Synthesis and antitumor activity of 5-azacytosine arabinoside

1 reference

12 December 2020

Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties

1 reference

12 December 2020

Arabinosyl-5-azacytosine: plasma kinetics and therapeutic response (L1210) in vitro and in vivo in mice

1 reference

12 December 2020

Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia

1 reference

12 December 2020

The synthesis and antitumor activity of arabinosyl-5-azacytosine

1 reference

12 December 2020

1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells

1 reference

12 December 2020

Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse

1 reference

12 December 2020

Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis

1 reference

12 December 2020

Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.

1 reference

12 December 2020

Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.

1 reference

12 December 2020

Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00169970

1 reference

Dimensions Publication ID

30 August 2017

1050164529

0 references

1 reference